| ARREX | VGSIX | ARREX / VGSIX | |
| Total Expense Ratio | 0.95 | 0.27 | 352% |
| Annual Report Gross Expense Ratio | 0.95 | 0.27 | 352% |
| Fund Existence | 9 years | 30 years | - |
| Gain YTD | 0.957 | 2.586 | 37% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 517M | 65.4B | 1% |
| Annual Yield % from dividends | 2.30 | 3.72 | 62% |
| Returns for 1 year | 0.39 | 2.00 | 19% |
| Returns for 3 years | 20.76 | 19.60 | 106% |
| Returns for 5 years | 8.81 | 25.58 | 34% |
| Returns for 10 years | N/A | 52.41 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TSMU | 43.65 | 1.09 | +2.55% |
| GraniteShares 2x Long TSM Daily ETF | |||
| RFI | 10.99 | 0.02 | +0.18% |
| Cohen and Steers Total Return Realty Fund | |||
| FFDI | 30.35 | 0.05 | +0.15% |
| Fidelity Fundamental Developed International ETF | |||
| IVOG | 123.20 | -0.08 | -0.06% |
| Vanguard S&P Mid-Cap 400 Growth ETF | |||
| IBBQ | 28.91 | -0.19 | -0.64% |
| Invesco Nasdaq Biotechnology ETF | |||